ALTA - Alterola Biotech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Alterola Biotech, Inc.

340 South Lemon Avenue
Suite 4041
Walnut, CA 91789
United States

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Rene LauritsenChief Operating OfficerN/AN/A1974
Mr. Peter MaddocksCEO, Pres, CFO, Principal Accounting Officer & DirectorN/AN/A1959
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Alterola Biotech, Inc., a development stage company, focuses on the development of nutrition and health chewing gums with natural based ingredients in the United States. Its products under development include appetite suppressors, cholesterol suppressors, antioxidant gums, motion sickness suppressors, and vitamin gums. The company was formerly known as Jedediah Resources Corp. and changed its name to Alterola Biotech, Inc. in July 2010. Alterola Biotech, Inc. was founded in 2008 and is based in Walnut, California. Alterola Biotech, Inc. is a subsidiary of London Pharma Holdings Limited.

Corporate Governance

Alterola Biotech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.